{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:59:33Z","timestamp":1791053973920,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008992","name":"Yantai University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008992","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.cbi.2023.110522","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T02:11:47Z","timestamp":1683771107000},"page":"110522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Synthesis and biological evaluation of resveratrol amide derivatives as selective COX-2 inhibitors"],"prefix":"10.1016","volume":"380","author":[{"given":"Min","family":"Xin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2023.110522_bib1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1248\/cpb.c16-00030","article-title":"Synthesis and biological evaluation of novel resveratrol-NSAID derivatives as anti-inflammatory agents","volume":"64","author":"Peng","year":"2016","journal-title":"Chem. Pharm. Bull. (Tokyo)."},{"key":"10.1016\/j.cbi.2023.110522_bib2","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.apsb.2022.01.002","article-title":"Recent development on COX-2 inhibitors as promising anti-inflammatory agents: the past 10 years","volume":"12","author":"Ju","year":"2022","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.cbi.2023.110522_bib3","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJMp048288","article-title":"Coxibs and cardiovascular disease","volume":"351","author":"Fitzgerald","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2023.110522_bib4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ejmech.2016.08.013","article-title":"Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: synthesis, biological activities in vitro and docking study","volume":"123","author":"Lamie","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110522_bib5","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1016\/S0021-9258(18)53294-4","article-title":"Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other Nonsteroidal anti-inflammatory drug","volume":"268","author":"Meade","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2023.110522_bib6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0223-5234(03)00115-6","article-title":"Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs","volume":"38","author":"Charlier","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110522_bib7","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1056\/NEJMp048286","article-title":"Use of NSAIDs in treating patients with arthritis","volume":"351","author":"Topol","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2023.110522_bib8","first-page":"7","article-title":"Selective cyclooxygenase-2 inhibitors","volume":"39","author":"Black","year":"2004","journal-title":"Annu. Rep. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110522_bib9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/joim.13505","article-title":"Lessons from 20 years with COX-2 inhibitors: importance of dose\u2013response considerations and fair play in comparative trials","volume":"292","author":"Stiller","year":"2022","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.cbi.2023.110522_bib10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejmech.2019.07.016","article-title":"Design of balanced COX inhibitors based on anti-inflammatory and\/or COX-2 inhibitory ascidian metabolites","volume":"180","author":"Ju","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110522_bib11","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.2174\/0929867327666200602131100","article-title":"Natural product inhibitors of cyclooxygenase (COX) enzyme: a review on current status and future perspectives","volume":"28","author":"Ambati","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110522_bib12","first-page":"2341","article-title":"Natural inhibitors against potential targets of cyclooxygenase, lipoxygenase and leukotrienes","volume":"25","author":"Dey","year":"2022","journal-title":"Comb. Chem. High. T. Scr."},{"key":"10.1016\/j.cbi.2023.110522_bib13","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1016\/j.bmc.2004.08.008","article-title":"Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship","volume":"12","author":"Murias","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110522_bib14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/mc.20437","article-title":"Resveratrol directly targets COX-2 to inhibit carcinogenesis","volume":"47","author":"Zykova","year":"2008","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.cbi.2023.110522_bib15","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/biof.111","article-title":"Effects of resveratrol and flavonols on cardiovascular function: physiological mechanisms","volume":"36","author":"Yap","year":"2010","journal-title":"Biofactors"},{"key":"10.1016\/j.cbi.2023.110522_bib16","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1021\/cn400094w","article-title":"Neuroprotective properties and mechanisms of resveratrol in in vitro and in vivo experimental cerebral stroke models","volume":"4","author":"Singh","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.cbi.2023.110522_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cbi.2011.12.007","article-title":"Differential protective effects of quercetin, resveratrol, rutin and epigallocatechin gallate against mitochondrial dysfunction induced by indomethacin in Caco-2 cells","volume":"195","author":"Carrasco-Pozo","year":"2012","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2023.110522_bib18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbrc.2009.02.027","article-title":"Biphasic activity of resveratrol on indomethacin-induced gastric ulcers","volume":"381","author":"Dey","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2023.110522_bib19","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3390\/nu10111651","article-title":"Resveratrol, metabolic syndrome, and gut microbiota","volume":"10","author":"Chaplin","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.cbi.2023.110522_bib20","doi-asserted-by":"crossref","first-page":"12290","DOI":"10.1021\/acs.jmedchem.0c00530","article-title":"Amide bond bioisosteres: strategies, synthesis, and successes","volume":"63","author":"Kumari","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110522_bib21","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1021\/ja00819a013","article-title":"Hydrogen bonding ability of the amide group","volume":"96","author":"Johansson","year":"1974","journal-title":"J. Am. Chem. Soc."},{"issue":"9","key":"10.1016\/j.cbi.2023.110522_bib22","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1358\/dof.1997.022.09.423212","article-title":"Atorvastatin calcium","volume":"22","author":"Graul","year":"1997","journal-title":"Drugs Future"},{"key":"10.1016\/j.cbi.2023.110522_bib23","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3390\/pharmaceutics15031028","article-title":"Antiviral mechanisms of N-phenyl benzamides on coxsackie virus A9","volume":"15","author":"Laajala","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cbi.2023.110522_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201900304","article-title":"Design, synthesis and in vitro tumor cytotoxicity evaluation of 3, 5\u2010diamino\u2010N\u2010substituted benzamide derivatives as novel GSK\u20103\u03b2 small molecule inhibitors","volume":"16","author":"Zhou","year":"2019","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.cbi.2023.110522_bib25","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.3390\/ijms24032745","article-title":"Synthesis, in silico study, antibacterial and antifungal activities of N-phenylbenzamides","volume":"24","author":"Sulistyowaty","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2023.110522_bib26","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1021\/acs.chemrestox.8b00175","article-title":"Amino-substituted benzamide derivatives as promising antioxidant agents: a combined experimental and computational study","volume":"31","author":"Perin","year":"2018","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2023.110522_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104610","article-title":"Synthesis and biological evaluation of new nicotinate derivatives as potential anti-inflammatory agents targeting COX-2 enzyme","volume":"107","author":"El-Dash","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.cbi.2023.110522_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.apsb.2015.03.013","article-title":"Synthesis and antiviral activity of a series of novel N-phenylbenzamide and N-phenylacetophenone compounds as anti-HCV and anti-EV71 agents","volume":"5","author":"Jiang","year":"2015","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.cbi.2023.110522_bib29","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ejmech.2018.04.007","article-title":"Discovery of novel Methylsulfonyl phenyl derivatives as potent human Cyclooxygenase-2 inhibitors with effective anticonvulsant action: design, synthesis, in-silico, in-vitro and in-vivo evaluation","volume":"151","author":"Mishra","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110522_bib30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejmech.2018.09.007","article-title":"Structural alterations based on naproxen scaffold: synthesis, evaluation of antitumor activity and COX-2 inhibition, and molecular docking","volume":"158","author":"El-Husseiny","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110522_bib31","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/S0960-894X(99)00481-3","article-title":"Structural basis of the dynamic mechanism of ligand binding to cyclooxygenase","volume":"9","author":"Llorens","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.cbi.2023.110522_bib32","first-page":"278","volume":"1441","author":"Garavito","year":"1999","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1016\/j.cbi.2023.110522_bib33","doi-asserted-by":"crossref","first-page":"7592","DOI":"10.1021\/acs.chemrev.0c00215","article-title":"Structural and chemical biology of the interaction of cyclooxygenase with substrates and non-steroidal anti-inflammatory drugs","volume":"120","author":"Rouzer","year":"2020","journal-title":"Chem. Rev."},{"key":"10.1016\/j.cbi.2023.110522_bib34","doi-asserted-by":"crossref","first-page":"S2778","DOI":"10.1016\/j.arabjc.2013.10.028","article-title":"Chemoselective N-benzoylation of aminophenols employing benzoylisothiocyanates","volume":"10","author":"Singh","year":"2017","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.cbi.2023.110522_bib35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/14756366.2011.642374","article-title":"N-arylbenzamides: extremely simple scaffolds for the development of novel estrogen receptor agonists","volume":"28","author":"Caldarelli","year":"2013","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110522_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14756366.2016.1217853","article-title":"Catechol-based matrix metalloproteinase inhibitors with additional antioxidative activity","volume":"31","author":"Tauro","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110522_bib37","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/cmdc.201500598","article-title":"Structure-based design of microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors using a virtual fragment growing optimization Scheme","volume":"11","author":"Lauro","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.cbi.2023.110522_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116344","article-title":"Discovery of pyrazole N-aryl sulfonate: a novel and highly potent cyclooxygenase-2 (COX-2) selective inhibitors","volume":"46","author":"Yao","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110522_bib39","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/jlb.65.6.792","article-title":"Blockade of nitric oxide formation down-regulates cyclooxygenase-2 and decreases pge2 biosynthesis in macrophages","volume":"65","author":"Perkins","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cbi.2023.110522_bib40","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1055\/s-0037-1610653","article-title":"Pd-catalyzed oxidation of aldimines to amides","volume":"29","author":"Gao","year":"2018","journal-title":"Synlett"},{"key":"10.1016\/j.cbi.2023.110522_bib41","first-page":"1417","article-title":"A highly efficient copper-catalyzed method for the synthesis of 2-hydroxybenzamides in water","volume":"44","author":"Balkrishna","year":"2012","journal-title":"ChemInform"},{"key":"10.1016\/j.cbi.2023.110522_bib42","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3390\/molecules27031096","article-title":"Discovery of novel non-oxime reactivators showing in vivo antidotal efficiency for sarin poisoned mice","volume":"27","author":"Wei","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2023.110522_bib43","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1080\/14756366.2022.2086867","article-title":"Synthesis and biological evaluation of thieno[3,2-c]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3\u03b2 inhibitors for Alzheimer's disease","volume":"37","author":"Yan","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110522_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172627","article-title":"Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation","volume":"862","author":"Ravishankar","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2023.110522_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2153-2435.1000296","article-title":"Synthesis and electrochemical evaluation of some organic molecules as an antioxidant agents","volume":"5","author":"Jamila Bouali","year":"2014","journal-title":"Pharm. Anal. Acta"},{"key":"10.1016\/j.cbi.2023.110522_bib46","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1055\/s-0031-1289755","article-title":"A highly efficient copper-catalyzed method for the synthesis of 2-hydroxybenzamides in water","volume":"44","author":"Balkrishna","year":"2012","journal-title":"Synthesis"},{"key":"10.1016\/j.cbi.2023.110522_bib47","doi-asserted-by":"crossref","first-page":"o1499","DOI":"10.1107\/S1600536812015620","article-title":"N-(3-Hy-droxy-phen-yl)nicotinamide","volume":"68","author":"Ge","year":"2012","journal-title":"Acta Crystallogr., Sect. E: Struct. Rep. Online"},{"key":"10.1016\/j.cbi.2023.110522_bib48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14756366.2016.1217853","article-title":"Catechol-based matrix metalloproteinase inhibitors with additional antioxidative activity","volume":"31","author":"Tauro","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110522_bib49","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/cmdc.201500598","article-title":"Structure-based design of microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors using a virtual fragment growing optimization Scheme","volume":"11","author":"Lauro","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.cbi.2023.110522_bib50","doi-asserted-by":"crossref","first-page":"o1300","DOI":"10.1107\/S1600536808018102","article-title":"2-Chloro-N-(3-chloro-phen-yl)benzamide","volume":"64","author":"Gowda","year":"2008","journal-title":"Acta Crystallogr., Sect. E: Struct. Rep. Online"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279723001898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279723001898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:14:22Z","timestamp":1757859262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279723001898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":50,"alternative-id":["S0009279723001898"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2023.110522","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of resveratrol amide derivatives as selective COX-2 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2023.110522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110522"}}